Effects of a metabotropic glutamate2/3 receptor agonist (LY544344/LY354740) on panic anxiety induced by cholecystokinin tetrapeptide in healthy humans: preliminary results

被引：0
|
作者：
Michael Kellner
Christoph Muhtz
Kristina Stark
Alexander Yassouridis
Josef Arlt
Klaus Wiedemann
机构：
[1] University Hospital Hamburg-Eppendorf,Department of Psychiatry and Psychotherapy
[2] Max Planck Institute of Psychiatry,undefined
来源：
Psychopharmacology | 2005年 / 179卷
关键词：
Metabotropic glutamate receptors; CCK-4; Panic; Anxiety; LY544344; ACTH; Cortisol; Prolactin;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：310 / 315
页数：5
相关论文
共 18 条
  • [1] Effects of a metabotropic glutamate2/3 receptor agonist (LY544344/LY354740) on panic anxiety induced by cholecystokinin tetrapeptide in healthy humans:: preliminary results
    Kellner, M
    Muhtz, C
    Stark, K
    Yassouridis, A
    Arlt, J
    Wiedemann, K
    PSYCHOPHARMACOLOGY, 2005, 179 (01) : 310 - 315
  • [2] A novel orally active group 2 metabotropic glutamate receptor agonist: LY354740
    Bond, A
    Monn, JA
    Lodge, D
    NEUROREPORT, 1997, 8 (06) : 1463 - 1466
  • [3] mGlu2/3 receptor agonist (LY354740) in anxiety
    Schoepp, Darryle D.
    PHARMACOLOGY BIOCHEMISTRY AND BEHAVIOR, 2024, 242
  • [4] LY354740, a potent group II metabotropic glutamate receptor agonist prevents lactate-induced panic-like response in panic-prone rats
    Shekhar, A
    Keim, SR
    NEUROPHARMACOLOGY, 2000, 39 (07) : 1139 - 1146
  • [5] Selective group II glutamate metabotropic receptor agonist LY354740 attenuates pentetrazole- and picrotoxin-induced seizures
    Klodzinska, A
    Chojnacka-Wójcik, E
    Pilc, A
    POLISH JOURNAL OF PHARMACOLOGY, 1999, 51 (06): : 543 - 545
  • [6] Preliminary evidence of attenuation of the disruptive effects of the NMDA glutamate receptor antagonist, ketamine, on working memory by pretreatment with the group II metabotropic glutamate receptor agonist, LY354740, in healthy human subjects
    John H. Krystal
    Walid Abi-Saab
    Edward Perry
    D. Cyril D’Souza
    Nianjin Liu
    Ralitza Gueorguieva
    Lisa McDougall
    Tracy Hunsberger
    Aysenil Belger
    Louise Levine
    Alan Breier
    Psychopharmacology, 2005, 179 : 303 - 309
  • [7] Preliminary evidence of attenuation of the disruptive effects of the NMDA glutamate receptor antagonist, ketamine, on working memory by pretreatment with the group II metabotropic glutamate receptor agonist, LY354740, in healthy human subjects
    Krystal, JH
    Abi-Saab, W
    Perry, E
    D'Souza, D
    Liu, NJ
    Gueorguieva, R
    McDougall, L
    Hunsberger, T
    Belger, A
    Levine, L
    Breier, A
    PSYCHOPHARMACOLOGY, 2005, 179 (01) : 303 - 309
  • [8] LY354740, an mGlu2/3 receptor agonist as a novel approach to treat anxiety/stress
    Schoepp, DD
    Wright, RA
    Levine, LR
    Gaydos, B
    Potter, WZ
    STRESS-THE INTERNATIONAL JOURNAL ON THE BIOLOGY OF STRESS, 2003, 6 (03): : 189 - 197
  • [9] Metabotropic glutamate2/3 receptor agonism facilitates autonomic recovery after pharmacological panic challenge in healthy humans
    Agorastos, Agorastos
    Demiralay, Cueneyt
    Stiedl, Oliver
    Muhtz, Christoph
    Wiedemann, Klaus
    Kellner, Michael
    INTERNATIONAL CLINICAL PSYCHOPHARMACOLOGY, 2016, 31 (03) : 176 - 178
  • [10] Modulation of amphetamine-induced dopamine release by group II metabotropic glutamate receptor agonist LY354740 in non-human primates studied with positron emission tomography
    van Berckel, BNM
    Kegeles, LS
    Waterhouse, R
    Guo, NN
    Hwang, DR
    Huang, YY
    Narendran, R
    Van Heertum, R
    Laruelle, M
    NEUROPSYCHOPHARMACOLOGY, 2006, 31 (05) : 967 - 977
12